Circle Health reaches $1 million ARR within six months of entering the US market; funds to accelerate sales, clinical teams, and technology
National, Founded in 2022 by Chaitanya Shravanth, Prerna Raman, Harshvardhan Samvatsar and Krishna G, Circle Health has developed an AI-native, outcomes-first care coordination platform serving the US senior care ecosystem. Its current customers include a combination of Indian and US-based healthcare facilities. The investment round, which was closed in February 2026, brought on A.P.T. Research and Momentum Capital, while existing investors Enzia Ventures and Sparrow Capital doubled down in this round. Proceeds from the investment will be deployed to build out Circle Health’s US sales team, expand its onshore and offshore clinical workforce, and accelerate development of its proprietary AI and technology platform.
The United States spends $1.6 trillion annually on Medicare, covering more than 70 million seniors through a post-acute ecosystem of over 17,000 Skilled Nursing Facilities, 40,000 Assisted Living Facilities, and 100,000 Home Health Agencies. Yet the system is haemorrhaging value, with hospital readmission rates for seniors sitting between 17–30%, generating $26 billion in avoidable hospitalisation costs each year. It is established that Care Coordination helps in reducing hospital readmissions by 15-30% and Emergency Department visits by 12-15%. While payment mechanisms for Care Coordination exist, for example, in the form of CCM, RPM and other programs through Medicare, the economics and effectiveness of implementations was poor until recently. This is rapidly changing with the advent of AI tools.
Circle Health has built an AI-Native Agency, a new category that combines AI-driven workflow automation, a global clinical workforce, and a fully configurable technology platform, all aligned through a revenue-share commercial structure that ties Circle’s economics directly to patient outcomes. At its core, Circle’s operating model works in three integrated layers. Circle’s AI engine drafts clinical notes, performs care gap analysis, monitors patient signals, and generates personalised care summaries, replacing the most time-consuming documentation burden that has historically made care coordination programmes impossible to scale. Circle’s clinical staff, including US-based medical assistants and nurse practitioners, supported by an offshore clinical pool, review, validate, and escalate. Circle’s proprietary technology platform handles billing compliance, configurable care flows, and real-time quality assurance across the entire operation.
“We started with a simple conviction: that care coordination should be measured by what happens to patients, not by how many minutes were logged.” said Chaitanya Shravanth, CEO of Circle Health. “Building that model in India where clients pay for outcomes, not effort, gave us something most US care coordination companies don’t have: the muscle memory of actually doing it. The $1 million ARR milestone in under a year is meaningful, but what excites us more is the pipeline because the demand from physician groups and SNF operators is not the constraint. Execution has always been the constraint. We are here to solve that and this funding round is a massive vote of confidence for us.”
Circle Health made its first visit to the United States in March 2025. By September 2025, it had collected initial revenue and by April 2026, exactly one year after entering the market, it crossed $1 million in ARR. The company currently serves clients across a pipeline spanning more than 400 facilities and thousands of beds, including multiple physician groups in the US.
“What drew us to Circle Health is the same thing that makes it genuinely hard to replicate: an outcome-orientation that was built under real pressure, in a market that only pays for results.” said Ankur Shrivastava, Managing Partner at Momentum Capital. “The team didn’t arrive in the US with a theory – they arrived with 100,000 lives of operational data, a clinical workforce already running across three continents, and an AI stack purpose-built for care execution rather than care documentation. In a market where the gap between eligible patients and enrolled patients is enormous, Circle has the infrastructure to close it and we’re thrilled to partner with them through this journey”
“We are bullish on the opportunity of building highly profitable companies from India for the large US healthcare market. Circle’s strongest differentiator is not just the outcomes it delivers, but the execution muscle its team has built to consistently deliver them. That muscle has translated into a go-to-market that resonates with key stakeholders across the US healthcare ecosystem. Crossing $1M ARR within six months, with $4–5M of revenue visibility from existing clients, is proof that Circle isn’t just ready for this market, it’s ready to take off from here,” said Jayshree Kanther Patodi, Co-founder and Partner at Enzia Ventures.
Disclaimer: The above press release has been provided by High Hopes . CXO Digital Pulse holds no responsibility for its content in any manner. Reproduction or Copying in part or whole is not permitted unless approved by author.
